Elizabeth Holmes, a Stanford University dropout once likened to Steve Jobs, was forced to pay a $500,000 fine and give up her blood-testing company Theranos after securities regulators said she fraudulently raised more than $700 million from investors.
Generic clopidogrel was equally effective as the brand-name antiplatelet Plavix for an older population with acute coronary syndrome (ACS), according to a study published in Circulation: Cardiovascular Quality and Outcomes.
Long-term dual antiplatelet therapy (DAPT) should remain the standard of care following implantation of drug-eluting stents, suggests research presented March 12 at the American College of Cardiology’s annual scientific session and published simultaneously online in The Lancet.
More than a quarter million deaths from cardiovascular disease (CVD) each year in the United States can be attributed to historical lead exposure in people age 44 and older, according to new estimates published in The Lancet Public Health.
C. Michael Valentine, MD, officially assumed his role as the new president of the American College of Cardiology on March 12 during a convocation ceremony at the organization’s annual scientific session in Orlando.
Researchers at the University of Maryland Medical Center are investigating whether a stem cell treatment can improve outcomes for children born with hypoplastic left heart syndrome, in which the left half of the heart is unable to pump blood.
Turbulent economic and political eras may impact measures of citizen health, a new study found—leading some experts to wonder what will be uncovered when we collect data from President Donald Trump’s tenure.
As federal officials struggle to tackle exorbitant pharmaceutical prices, at least one drug’s manufacturers have pledged to slash prices of a potentially life-saving drug for its most at-risk patients.